Gastrointestinal dysfunction in liver cirrhosis

World Journal of Gastroenterology

Volumn 20, Issue 40, 2014, Pages 14686-14695

  Kalaitzakis, Evangelos ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastric accommodation; Gastrointestinal symptoms; Gut motility; Intestinal permeability; Liver cirrhosis; Malnutrition

Indexed keywords

BACTERIAL DNA; ENDOTOXIN; GHRELIN; GLUCOSE; INSULIN; TESTOSTERONE; TRYPTOPHAN;

ABDOMINAL PAIN; ALCOHOL LIVER CIRRHOSIS; ASCITES; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; BLOATING; CALORIC INTAKE; CHILD PUGH SCORE; CONSTIPATION; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DISTRESS SYNDROME; DYSPEPSIA; ENERGY EXPENDITURE; EPIGASTRIC PAIN; ERUCTATION; ESOPHAGUS VARICES; FOOD INTAKE; GASTROINTESTINAL TRANSIT; HELICOBACTER INFECTION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INTESTINE MOTILITY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALABSORPTION; MALNUTRITION; MANOMETRY; MODEL FOR END STAGE LIVER DISEASE SCORE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; PALATABILITY; PARTIAL GASTRECTOMY; PATHOGENESIS; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERCEPTIVE THRESHOLD; PERMEABILITY; PORTAL HYPERTENSION; QUALITY OF LIFE; REVIEW; SATIETY; SENSORIMOTOR FUNCTION; SMALL BOWEL MANOMETRY; STOMACH DISTENSION; STOMACH EMPTYING; STOMACH FUNDOPLICATION; TESTOSTERONE BLOOD LEVEL; TRYPTOPHAN BRAIN LEVEL; VAGOTOMY; ANIMAL; COMPLICATION; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; INNERVATION; INTESTINE INNERVATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ANIMALS; BACTERIAL TRANSLOCATION; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; LIVER CIRRHOSIS; MALNUTRITION; NUTRITIONAL STATUS; PERMEABILITY; PROGNOSIS; RISK FACTORS;

EID: 84910608403     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i40.14686     Document Type: Review

References (140)

1. Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, Roffi L, Failla M, Grassi G, Giannattasio C, Mancia G. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131-1137 [PMID: 9362352]
2. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26: 842-847 [PMID: 12434095]
3. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363: 1461-1468 [PMID: 15121411 DOI: 10.1016/S0140-6736(04)16107-2]
4. Cárdenas A. Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol 2005; 100: 460-467 [PMID: 15667508 DOI: 10.1111/j.1572-0241.2005.40952.x]
5. Pham PT, Pham PC, Rastogi A, Wilkinson AH. Review article: current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 2005; 21: 949-961 [PMID: 15813830 DOI: 10.1111/j.1365-2036.2005.02357.x]
6. Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996; 11: 417-421 [PMID: 8743912 DOI: 10.1111/j.1440-1746.1996.tb00284.x]
7. Monegal A, Navasa M, Guañabens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rodés J, Muñoz-Gómez J. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997; 60: 148-154 [PMID: 9056162 DOI: 10.1007/s002239900205]
8. Matos C, Porayko MK, Francisco-Ziller N, DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol 2002; 35: 391-397 [PMID: 12394227 DOI: 10.1097/00004836-200211000-00007]
9. Viggiano TR, Gostout CJ. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. Am J Gastroenterol 1992; 87: 944-954 [PMID: 1642217]
10. Campillo B, Bories PN, Pornin B, Devanlay M. Influence of liver failure, ascites, and energy expenditure on the response to oral nutrition in alcoholic liver cirrhosis. Nutrition 1997; 13: 613-621 [PMID: 9263252 DOI: 10.1016/S0899-9007(97)83001-8]
11. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25: 652-657 [PMID: 9049214 DOI: 10.1002/hep.510250327]
12. Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001; 17: 761-765 [PMID: 11527674 DOI: 10.1016/S0899-9007(01)00626-8]
13. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003; 19: 515-521 [PMID: 12781851 DOI: 10.1016/S0899-9007(02)01071-7]
14. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-73, 173.e1 [PMID: 21893129 DOI: 10.1016/j.cgh.2011.08.028]
15. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR, Sawyer MB. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013; 47: 861-870 [PMID: 23751844 DOI: 10.1097/MCG.0b013e318293a825]
16. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, Esfandiari N, Baracos V, Montano-Loza AJ, Myers RP. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012; 18: 1209-1216 [PMID: 22740290 DOI: 10.1002/lt.23495]
17. Kalaitzakis E, Josefsson A, Castedal M, Henfridsson P, Bengtsson M, Andersson B, Björnsson E. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis. Scand J Gastroenterol 2013; 48: 577-584 [PMID: 23452072 DOI: 10.3109/00365521.2013.777468]
18. Davidson HI, Richardson R, Sutherland D, Garden OJ. Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. Hepatology 1999; 29: 1380-1386 [PMID: 10216119 DOI: 10.1002/hep.510290531]
19. Müller MJ, Lautz HU, Plogmann B, Bürger M, Körber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15: 782-794 [PMID: 1568718 DOI: 10.1002/hep.1840150507]
20. Müller MJ, Böttcher J, Selberg O, Weselmann S, Böker KH, Schwarze M, von zur Mühlen A, Manns MP. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999; 69: 1194-1201 [PMID: 10357739]
21. Madden AM, Morgan MY. Resting energy expenditure should be measured in patients with cirrhosis, not predicted. Hepatology 1999; 30: 655-664 [PMID: 10462371 DOI: 10.1002/hep.510300326]
22. Romiti A, Merli M, Martorano M, Parrilli G, Martino F, Riggio O, Truscelli A, Capocaccia L, Budillon G. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol 1990; 22: 118-123 [PMID: 2131941]
23. Laviano A, Cangiano C, Preziosa I, Riggio O, Conversano L, Cascino A, Ariemma S, Rossi Fanelli F. Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat Disord 1997; 21: 181-186 [PMID: 9062842 DOI: 10.1002/(SICI)1098-108X(199703)21]
24. Scolapio JS, Ukleja A, McGreevy K, Burnett OL, O'Brien PC. Nutritional problems in end-stage liver disease: contribution of impaired gastric emptying and ascites. J Clin Gastroenterol 2002; 34: 89-93 [PMID: 11743254 DOI: 10.1097/00004836-200201000-00018]
25. Kalaitzakis E, Simrén M, Olsson R, Henfridsson P, Hugosson I, Bengtsson M, Björnsson E. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol 2006; 41: 1464-1472 [PMID: 17101578 DOI: 10.1080/00365520600825117]
26. Kalaitzakis E, Josefsson A, Castedal M, Henfridsson P, Bengtsson M, Andersson B, Björnsson E. Gastrointestinal symptoms in patients with cirrhosis: a longitudinal study before and after liver transplantation. Scand J Gastroenterol 2013; 48: 1308-1316 [PMID: 24063547 DOI: 10.3109/00365521.2013.836755]
27. Kalaitzakis E, Simrén M, Abrahamsson H, Björnsson E. Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis. Scand J Gastroenterol 2007; 42: 237-246 [PMID: 17327944 DOI: 10.1080/00365520600880898]
28. Kalaitzakis E, Bosaeus I, Ohman L, Björnsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007; 85: 808-815 [PMID: 17344504]
29. Greco AV, Mingrone G, Benedetti G, Capristo E, Tataranni PA, Gasbarrini G. Daily energy and substrate metabolism in patients with cirrhosis. Hepatology 1998; 27: 346-350 [PMID: 9462629 DOI: 10.1002/hep.510270205]
30. Merli M, Riggio O, Romiti A, Ariosto F, Mango L, Pinto G, Savioli M, Capocaccia L. Basal energy production rate and substrate use in stable cirrhotic patients. Hepatology 1990; 12: 106-112 [PMID: 2373471 DOI: 10.1002/hep.1840120117]
31. Ockenga J, Bischoff SC, Tillmann HL, Rifai K, Widjaja A, Böker KH, Manns MP, Brabant G. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000; 119: 1656-1662 [PMID: 11113087 DOI: 10.1053/gast.2000.20256]
32. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11: 755-759 [PMID: 10445796 DOI: 10.1097/00042737-199907000-00013]
33. Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1985; 1: 513-524 [PMID: 4056352 DOI: 10.1016/S0168-8278(85)80749-2]
34. Fritz E, Hammer J. Gastrointestinal symptoms in patients with liver cirrhosis are linked to impaired quality of life and psychological distress. Eur J Gastroenterol Hepatol 2009; 21: 460-465 [PMID: 19382343 DOI: 10.1097/MEG.0b013e328318ed19]
35. Kotfila R, Trudeau W. Extraesophageal varices. Dig Dis 1998; 16: 232-241 [PMID: 9732183 DOI: 10.1159/000016871]
36. Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992; 6: 437-450 [PMID: 1421594 DOI: 10.1016/0950-3528(92)90031-9]
37. Gunnarsdottir SA, Olsson R, Björnsson ES. Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999. Scand J Gastroenterol 2005; 40: 1462-1468 [PMID: 16293558 DOI: 10.1080/00365520510023783]
38. Hosking SW. Congestive gastropathy in portal hypertension: variations in prevalence. Hepatology 1989; 10: 257-258 [PMID: 2663698]
39. Cubillas R, Rockey DC. Portal hypertensive gastropathy: a review. Liver Int 2010; 30: 1094-1102 [PMID: 20536720 DOI: 10.1111/j.1478-3231.2010.02286.x]
40. Merli M, Nicolini G, Angeloni S, Gentili F, Attili AF, Riggio O. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004; 99: 1959-1965 [PMID: 15447756 DOI: 10.1111/j.1572-0241.2004.40246.x]
41. Kim MY, Choi H, Baik SK, Yea CJ, Won CS, Byun JW, Park SY, Kwon YH, Kim JW, Kim HS, Kwon SO, Kim YJ, Cha SH, Chang SJ. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci 2010; 55: 3561-3567 [PMID: 20407828 DOI: 10.1007/s10620-010-1221-6]
42. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119: 181-187 [PMID: 10889167]
43. Konturek SJ, Gonciarz M, Gonciarz Z, Bielanski W, Mazur W, Mularczyk A, Konturek PC, Goetze JP, Rehfeld JF. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. Scand J Gastroenterol 2003; 38: 643-647 [PMID: 12825873]
44. Wu CS, Lin CY, Liaw YF. Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointest Endosc 1995; 42: 424-427 [PMID: 8566632]
45. Chen LS, Lin HC, Hwang SJ, Lee FY, Hou MC, Lee SD. Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol 1996; 11: 59-64 [PMID: 8672743]
46. Siringo S, Burroughs AK, Bolondi L, Muia A, Di Febo G, Miglioli M, Cavalli G, Barbara L. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22: 633-641 [PMID: 7560857 DOI: 10.1016/0168-8278(95)80219-3]
47. Siringo S, Bolondi L, Piscaglia F, Gaetani M, Misitano B, Carbone C, Corinaldesi R, Burroughs AK. Peptic ulcer in patients with liver cirrhosis: a retrospective endoscopic and clinical study. Ital J Gastroenterol Hepatol 1997; 29: 62-68 [PMID: 9265582]
48. Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14: 717-722 [PMID: 12169979 DOI: 10.1097/00042737-200207000-00002]
49. Chang SS, Hu HY. Helicobacter pylori is not the predominant etiology for liver cirrhosis patients with peptic ulcer disease. Eur J Gastroenterol Hepatol 2013; 25: 159-165 [PMID: 23044811 DOI: 10.1097/MEG.0b013e32835a1b26]
50. Rudler M, Rousseau G, Benosman H, Massard J, Deforges L, Lebray P, Poynard T, Thabut D. Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis? Aliment Pharmacol Ther 2012; 36: 166-172 [PMID: 22607536 DOI: 10.1111/j.1365-2036.2012.05140.x]
51. Luo JC, Leu HB, Hou MC, Huang CC, Lin HC, Lee FY, Chang FY, Chan WL, Lin SJ, Chen JW. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther 2012; 36: 542-550 [PMID: 22817655 DOI: 10.1111/j.1365-2036.2012.05225.x]
52. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology 2012; 56: 698-705 [PMID: 22378148 DOI: 10.1002/hep.25684]
53. Azpiroz F, Malagelada JR. Physiological variations in canine gastric tone measured by an electronic barostat. Am J Physiol 1985; 248: G229-G237 [PMID: 3970203]
54. Azpiroz F, Malagelada JR. Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am J Physiol 1986; 251: G727-G735 [PMID: 3789139]
55. Azpiroz F, Malagelada JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987; 92: 934-943 [PMID: 3556999]
56. Jahnberg T, Abrahamsson H, Jansson G, Martinson J. Gastric relaxatory response to feeding before and after vagotomy. Scand J Gastroenterol 1977; 12: 225-228 [PMID: 847390]
57. Tack J, Demedts I, Meulemans A, Schuurkes J, Janssens J. Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut 2002; 51: 219-224 [PMID: 12117883 DOI: 10.1136/gut.51.2.219]
58. Kuiken SD, Vergeer M, Heisterkamp SH, Tytgat GN, Boeckxstaens GE. Role of nitric oxide in gastric motor and sensory functions in healthy subjects. Gut 2002; 51: 212-218 [PMID: 12117882 DOI: 10.1136/gut.51.2.212]
59. De Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004; 16: 275-285 [PMID: 15198649 DOI: 10.1111/j.1365-2982.2004.00497.x]
60. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996; 41: 689-696 [PMID: 8674389 DOI: 10.1007/BF02213124]
61. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352 [PMID: 9834261 DOI: 10.1016/S0016-5085(98)70012-5]
62. Undeland KA, Hausken T, Gilja OH, Aanderud S, Berstad A. Gastric meal accommodation studied by ultrasound in diabetes. Relation to vagal tone. Scand J Gastroenterol 1998; 33: 236-241 [PMID: 9548614 DOI: 10.1080/00365529850170784]
63. Wijnhoven BP, Salet GA, Roelofs JM, Smout AJ, Akkermans LM, Gooszen HG. Function of the proximal stomach after Nissen fundoplication. Br J Surg 1998; 85: 267-271 [PMID: 9501833 DOI: 10.1046/j.1365-2168.1998.00505.x]
64. Le Blanc-Louvry I, Savoye G, Maillot C, Denis P, Ducrotté P. An impaired accommodation of the proximal stomach to a meal is associated with symptoms after distal gastrectomy. Am J Gastroenterol 2003; 98: 2642-2647 [PMID: 14687810 DOI: 10.1016/j.amjgastroenterol.2003.08.026]
65. Izbéki F, Kiss I, Wittmann T, Várkonyi TT, Légrády P, Lonovics J. Impaired accommodation of proximal stomach in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 2002; 37: 1403-1410 [PMID: 12523589 DOI: 10.1080/003655202762671279]
66. Aqel BA, Scolapio JS, Dickson RC, Burton DD, Bouras EP. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005; 3: 1095-1100 [PMID: 16271340 DOI: 10.1016/S1542-3565(05)00531-8]
67. Notivol R, Coffin B, Azpiroz F, Mearin F, Serra J, Malagelada JR. Gastric tone determines the sensitivity of the stomach to distention. Gastroenterology 1995; 108: 330-336 [PMID: 7835573 DOI: 10.1016/0016-5085(95)90057-8]
68. Distrutti E, Azpiroz F, Soldevilla A, Malagelada JR. Gastric wall tension determines perception of gastric distention. Gastroenterology 1999; 116: 1035-1042 [PMID: 10220495 DOI: 10.1016/S0016-5085(99)70006-5]
69. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-535 [PMID: 11522735 DOI: 10.1053/gast.2001.27180]
70. Björnsson E, Sjöberg J, Ringström G, Norström M, Simrén M, Abrahamsson H. Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dys-motility- like dyspepsia. Digestion 2003; 67: 209-217 [PMID: 12966228 DOI: 10.1159/000072059]
71. Tack J. Gastric motor and sensory function. Curr Opin Gastroenterol 2005; 21: 665-672 [PMID: 16220042 DOI: 10.1097/01. mog.0000182864.34540.a0]
72. Sadik R, Abrahamsson H, Björnsson E, Gunnarsdottir A, Stotzer PO. Etiology of portal hypertension may influence gastrointestinal transit. Scand J Gastroenterol 2003; 38: 1039-1044 [PMID: 14621277 DOI: 10.1080/00365520310004939]
73. Acalovschi M, Dumitra¸cu DL, Csakany I. Gastric and gall bladder emptying of a mixed meal are not coordinated in liver cirrhosis - a simultaneous sonographic study. Gut 1997; 40: 412-417 [PMID: 9135534]
74. Galati JS, Holdeman KP, Dalrymple GV, Harrison KA, Quigley EM. Delayed gastric emptying of both the liquid and solid components of a meal in chronic liver disease. Am J Gastroenterol 1994; 89: 708-711 [PMID: 8172142]
75. Schoonjans R, Van Vlem B, Vandamme W, Van Vlierberghe H, Van Heddeghem N, Van Biesen W, Mast A, Sas S, Vanholder R, Lameire N, De Vos M. Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterol Hepatol 2002; 14: 395-398 [PMID: 11943952 DOI: 10.1097/00042737-200204000-00010]
76. Kalaitzakis E, Sadik R, Holst JJ, Ohman L, Björnsson E. Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis. Clin Gastroenterol Hepatol 2009; 7: 346-352 [PMID: 19200458]
77. Galati JS, Holdeman KP, Bottjen PL, Quigley EM. Gastric emptying and orocecal transit in portal hypertension and end-stage chronic liver disease. Liver Transpl Surg 1997; 3: 34-38 [PMID: 9377756 DOI: 10.1002/lt.500030105]
78. Van Thiel DH, Fagiuoli S, Wright HI, Chien MC, Gavaler JS. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology 1994; 19: 67-71 [PMID: 8276369 DOI: 10.1002/hep.1840190112]
79. Madsen JL, Brinch K, Hansen EF, Fuglsang S. Gastrointestinal motor function in patients with portal hypertension. Scand J Gastroenterol 2000; 35: 490-493 [PMID: 10868451 DOI: 10.1080/003655200750023741]
80. Karlsen S, Fynne L, Grønbæk H, Krogh K. Small intestinal transit in patients with liver cirrhosis and portal hypertension: a descriptive study. BMC Gastroenterol 2012; 12: 176 [PMID: 23216853 DOI: 10.1186/1471-230X-12-176]
81. Dumitrascu DL, Barnert J, Wienbeck M. Gastric emptying in liver cirrhosis. The effect of the type of meal. Eur J Gastroenterol Hepatol 1997; 9: 1073-1080 [PMID: 9431897 DOI: 10.1097/00042737-199711000-00009]
82. Björnsson ES, Urbanavicius V, Eliasson B, Attvall S, Smith U, Abrahamsson H. Effects of hyperglycemia on interdigestive gastrointestinal motility in humans. Scand J Gastroenterol 1994; 29: 1096-1104 [PMID: 7886397 DOI: 10.3109/00365529409094894]
83. Jones KL, Berry M, Kong MF, Kwiatek MA, Samsom M, Horowitz M. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999; 22: 339-344 [PMID: 10333955 DOI: 10.2337/diacare.22.2.339]
84. Hebbard GS, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects. Eur J Gastroenterol Hepatol 1996; 8: 211-217 [PMID: 8724019 DOI: 10.1097/00042737-199603000-00005]
85. Horowitz M, Harding PE, Maddox AF, Wishart JM, Akkermans LM, Chatterton BE, Shearman DJ. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 151-159 [PMID: 2753246 DOI: 10.1007/BF00265086]
86. Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36: 857-862 [PMID: 8405758 DOI: 10.1007/BF00400362]
87. Eliasson B, Björnsson E, Urbanavicius V, Andersson H, Fowelin J, Attvall S, Abrahamsson H, Smith U. Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption. Diabetologia 1995; 38: 79-85 [PMID: 7744232 DOI: 10.1007/BF02369356]
88. Kong MF, King P, Macdonald IA, Blackshaw PE, Perkins AC, Armstrong E, Buchanan KD, Tattersall RB. Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects. Diabetologia 1998; 41: 474-481 [PMID: 9562353 DOI: 10.1007/s001250050932]
89. Verne GN, Soldevia-Pico C, Robinson ME, Spicer KM, Reuben A. Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol 2004; 38: 72-76 [PMID: 14679331 DOI: 10.1097/00004836-200401000-00015]
90. Chesta J, Defilippi C, Defilippi C. Abnormalities in proximal small bowel motility in patients with cirrhosis. Hepatology 1993; 17: 828-832 [PMID: 8491451]
91. Madrid AM, Cumsille F, Defilippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 1997; 42: 738-742 [PMID: 9125642 DOI: 10.1023/A:1018899611006]
92. Chang CS, Chen GH, Lien HC, Yeh HZ. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 1998; 28: 1187-1190 [PMID: 9794900 DOI: 10.1002/hep.510280504]
93. Gunnarsdottir SA, Sadik R, Shev S, Simrén M, Sjövall H, Stotzer PO, Abrahamsson H, Olsson R, Björnsson ES. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98: 1362-1370 [PMID: 12818282 DOI: 10.1111/j.1572-0241.2003.07475.x]
94. Madrid AM, Brahm J, Buckel E, Silva G, Defilippi C. Orthotopic liver transplantation improves small bowel motility disorders in cirrhotic patients. Am J Gastroenterol 1997; 92: 1044-1045 [PMID: 9177529]
95. Nagasako CK, de Oliveira Figueiredo MJ, de Souza Almeida JR, Lorena SL, Akasaka HM, Pavan CR, Yamanaka A, Pereira TS, Soares EC, Mesquita MA. Investigation of autonomic function and orocecal transit time in patients with nonalcoholic cirrhosis and the potential influence of these factors on disease outcome. J Clin Gastroenterol 2009; 43: 884-889 [PMID: 19295446 DOI: 10.1097/MCG.0b013e31818de34c]
96. Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010; 53: 849-855 [PMID: 20675008 DOI: 10.1016/j.jhep.2010.05.017]
97. Chander Roland B, Garcia-Tsao G, Ciarleglio MM, Deng Y, Sheth A. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. J Clin Gastroenterol 2013; 47: 888-893 [PMID: 23632359 DOI: 10.1097/MCG.0b013e31829006bb]
98. Sadik R, Stotzer PO, Simrén M, Abrahamsson H. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil 2008; 20: 197-205 [PMID: 17999649 DOI: 10.1111/j.1365-2982.2007.01025.x]
99. Casafont Morencos F, de las Heras Castaño G, Martín Ramos L, López Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996; 41: 552-556 [PMID: 8617135 DOI: 10.1007/BF02282340]
100. Pande C, Kumar A, Sarin SK. Small-intestinal bacterial over-growth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009; 29: 1273-1281 [PMID: 19302262 DOI: 10.1111/j.1365-2036.2009.03994.x]
101. Pardo A, Bartolí R, Lorenzo-Zúñiga V, Planas R, Viñado B, Riba J, Cabré E, Santos J, Luque T, Ausina V, Gassull MA. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-863 [PMID: 10733540 DOI: 10.1053/he.2000.5746]
102. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002; 34: 385-396 [PMID: 11907349 DOI: 10.1097/000048 36-200204000-00003]
103. Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol 2003; 18: 479-497 [PMID: 12702039 DOI: 10.1046/j.1440-1746.2003.03032.x]
104. Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol 2012; 46 Suppl: S12-S17 [PMID: 22955350 DOI: 10.1097/MCG.0b013e31826ae849]
105. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-1581 [PMID: 7729650 DOI: 10.1016/0016-5085(95)90708-4]
106. Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-148 [PMID: 11786970 DOI: 10.1053/jhep.2002.30082]
107. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139: 1246-156, 1246-156, [PMID: 20558165 DOI: 10.1053/j.gastro.2010.06.019]
108. Francés R, Muñoz C, Zapater P, Uceda F, Gascón I, Pascual S, Pérez-Mateo M, Such J. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites. Gut 2004; 53: 860-864 [PMID: 15138214 DOI: 10.1136/gut.2003.027425]
109. Pascual S, Such J, Esteban A, Zapater P, Casellas JA, Aparicio JR, Girona E, Gutiérrez A, Carnices F, Palazón JM, Sola-Vera J, Pérez-Mateo M. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50: 1482-1486 [PMID: 14571769]
110. Ersöz G, Aydin A, Erdem S, Yüksel D, Akarca U, Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 409-412 [PMID: 10321758 DOI: 10.1097/00042737-199904000-00009]
111. Bac DJ, van der Berg JWO, Wilson JHP. Small bowel wall function in patients with advanced liver cirrhosis and portal hypertension: studies on permeability and luminal bacterial overgrowth. Eur J Gastroenterol Hepatol 1993; 5: 383-387 [DOI: 10.1097/00042737-199305000-00014]
112. Fujii T, Seki T, Maruoka M, Tanaka J, Kawashima Y, Watanabe T, Sawamura T, Inoue K. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 2001; 19: 158-169 [PMID: 11164740 DOI: 10.1016/S1386-6346(00)00099-1]
113. Huglo D, De Botton S, Canva-Delcambre V, Colombel JF, Wallaert B, Steinling M, Marchandise X. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001; 28: 1505-1511 [PMID: 11685493 DOI: 10.1007/s002590100589]
114. Zuckerman MJ, Menzies IS, Ho H, Gregory GG, Casner NA, Crane RS, Hernandez JA. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004; 49: 621-626 [PMID: 15185867 DOI: 10.1023/B:DDAS.0000026307.56909.21]
115. Kalaitzakis E, Johansson JE, Bjarnason I, Björnsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 2006; 41: 326-330 [PMID: 16497621]
116. Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol 2013; 58: 911-921 [PMID: 23262249 DOI: 10.1016/j.jhep.2012.12.011]
117. Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, Ghirlanda G, Gasbarrini A. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105: 323-327 [PMID: 19844200 DOI: 10.1038/ajg.2009.558]
118. Pijls KE, Jonkers DM, Elamin EE, Masclee AA, Koek GH. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver Int 2013; 33: 1457-1469 [PMID: 23879434 DOI: 10.1111/liv.12271]
119. Kim BI, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim HS, Kim DJ. Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage. J Gastroenterol Hepatol 2011; 26: 550-557 [PMID: 21332551 DOI: 10.1111/j.1440-1746.2010.06490.x]
120. Benjamin J, Singla V, Arora I, Sood S, Joshi YK. Intestinal permeability and complications in liver cirrhosis: A prospective cohort study. Hepatol Res 2013; 43: 200-207 [PMID: 22726344 DOI: 10.1111/j.1872-034X.2012.01054.x]
121. Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17: 27-31 [PMID: 15647636]
122. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-1449 [PMID: 15122774 DOI: 10.1002/hep.20194]
123. Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33: 662-671 [PMID: 21251030 DOI: 10.1111/j.1365-2036.2010.04574.x]
124. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-217 [PMID: 12500206 DOI: 10.1053/jhep.2003.50038]
125. Du Plessis J, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI, Nieuwoudt M, van Wyk SG, Vieira W, Pretorius E, Beukes M, Farré R, Tack J, Laleman W, Fevery J, Nevens F, Roskams T, Van der Merwe SW. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol 2013; 58: 1125-1132 [PMID: 23402745 DOI: 10.1016/j.jhep.2013.01.038]
126. Montes-de-Oca M, Blanco MJ, Marquez M, Soto MJ, Fernandez-Gutiérrez C, Rodriguez-Ramos C, Giron Gonzalez JA. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Liver Int 2011; 31: 850-858 [PMID: 21645216 DOI: 10.1111/j.1478-3231.2011.02505.x]
127. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2011; 141: 1220-130, 1220-130, [PMID: 21726511 DOI: 10.1053/j.gastro.2011.06.063]
128. Vlachogiannakos J, Saveriadis AS, Viazis N, Theodoropoulos I, Foudoulis K, Manolakopoulos S, Raptis S, Karamanolis DG. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Ther 2009; 29: 992-999 [PMID: 19210289 DOI: 10.1111/j.1365-2036.2009.03958.x]
129. Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci 2013; 58: 3029-3036 [PMID: 23907333 DOI: 10.1007/s10620-013-2693-y]
130. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999; 94: 200-207 [PMID: 9934756 DOI: 10.1111/j.1572-0241.1999.00797.x]
131. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; 1: 179-182 [PMID: 6141332]
132. Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 2000; 32: 742-747 [PMID: 10845660]
133. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol 2009; 50: 538-547 [PMID: 19155080 DOI: 10.1016/j.jhep.2008.10.028]
134. Ramachandran A, Balasubramanian KA. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2001; 16: 607-612 [PMID: 11422611]
135. Elamin EE, Masclee AA, Dekker J, Jonkers DM. Ethanol metabolism and its effects on the intestinal epithelial barrier. Nutr Rev 2013; 71: 483-499 [PMID: 23815146 DOI: 10.1111/nure.12027]
136. Tang Y, Forsyth CB, Farhadi A, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ, Keshavarzian A. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res 2009; 33: 1220-1230 [PMID: 19389191 DOI: 10.1111/j.1530-0277.2009.00946.x]
137. Norman DA, Atkins JM, Seelig LL, Gomez-Sanchez C, Krejs GJ. Water and electrolyte movement and mucosal morphology in the jejunum of patients with portal hypertension. Gastroenterology 1980; 79: 707-715 [PMID: 7409388]
138. Yu LC, Wang JT, Wei SC, Ni YH. Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. World J Gastrointest Pathophysiol 2012; 3: 27-43 [PMID: 22368784 DOI: 10.4291/wjgp.v3.i1.27]
139. Teltschik Z, Wiest R, Beisner J, Nuding S, Hofmann C, Schoelmerich J, Bevins CL, Stange EF, Wehkamp J. Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. Hepatology 2012; 55: 1154-1163 [PMID: 22095436 DOI: 10.1002/hep.24789]
140. Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, Spiliopoulou I, Kaltezioti V, Charonis A, Nikolopoulou VN, Scopa CD, Thomopoulos KC. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest 2012; 42: 439-446 [PMID: 22023490 DOI: 10.1111/j.1365-2362.2011.02609.x]